CN106442986A - Method for detecting regional SIV (swine influenza virus) subtype distribution - Google Patents
Method for detecting regional SIV (swine influenza virus) subtype distribution Download PDFInfo
- Publication number
- CN106442986A CN106442986A CN201610837384.1A CN201610837384A CN106442986A CN 106442986 A CN106442986 A CN 106442986A CN 201610837384 A CN201610837384 A CN 201610837384A CN 106442986 A CN106442986 A CN 106442986A
- Authority
- CN
- China
- Prior art keywords
- serum
- hole
- tested
- checked
- influenza virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
本发明涉及一种检测区域性猪流感病毒亚型分布的方法,属于动物卫生检测技术领域,其特征在于,包括以下步骤:首先采集血清样品,采用“胰酶‑高铁酸钠‑过氧化氢‑聚乙二醇”方法处理血清样品,去除其中的非特异性凝血因子,得待检血清;采用倍比稀释的方法确定4个血凝单位的抗原浓度;在V型微量反应板上使待检血清、待检抗原和鸡红细胞悬液发生反应,以完全抑制4个血凝单位待检抗原的待检血清的最高稀释倍数作为血清抗体的效价,确定血清抗体效价为阳性的待检血清。本发明所述方法简单有效,成本低,可用于对数量较多的血清样品进行阳性率分析,为动物疾病治疗与预防奠定基础。The invention relates to a method for detecting the distribution of regional swine influenza virus subtypes, which belongs to the technical field of animal health detection, and is characterized in that it comprises the following steps: first collecting serum samples, using "pancreatin-sodium ferrate-hydrogen peroxide- Polyethylene glycol" method was used to process serum samples to remove the non-specific coagulation factors to obtain the serum to be tested; the method of doubling dilution was used to determine the antigen concentration of 4 hemagglutination units; the serum to be tested was prepared on a V-type microplate 1. The antigen to be tested reacts with the chicken red blood cell suspension, and the highest dilution factor of the serum to be tested that completely inhibits the antigen to be tested by 4 hemagglutination units is used as the titer of the serum antibody to determine that the titer of the serum antibody is positive for the serum to be tested. The method of the invention is simple, effective and low in cost, and can be used to analyze the positive rate of a large number of serum samples, laying a foundation for the treatment and prevention of animal diseases.
Description
技术领域technical field
本发明属于动物卫生检测技术领域,具体地涉及一种检测区域性猪流感病毒亚型分布的方法。The invention belongs to the technical field of animal health detection, and in particular relates to a method for detecting regional swine influenza virus subtype distribution.
背景技术Background technique
猪流感病毒(Swine Influenza Virus,SIV)在分类上属于正粘病毒科、A型流感病毒属,单股负链RNA病毒,基因组由大小不等的8个独立片段组成,能引起一种猪的三类动物疫病,H1N1、H3N2和H1N2亚型猪流感病毒是猪群中广泛存在并频繁引起猪群发病的毒株。单纯的SIV感染具有发病率高、死亡率低的特点,但猪流感是典型的免疫抑制性疾病,会引起其他病原的混合或继发感染,进而造成严重的经济损失。Swine Influenza Virus (SIV) belongs to Orthomyxoviridae and Influenzavirus A in classification. It is a single-stranded negative-strand RNA virus. The genome is composed of 8 independent segments of different sizes. Animal diseases, H1N1, H3N2 and H1N2 subtype swine influenza viruses are strains that are widespread in pigs and frequently cause disease in pigs. Simple SIV infection has the characteristics of high morbidity and low mortality, but swine influenza is a typical immunosuppressive disease, which will cause mixed or secondary infection of other pathogens, and cause serious economic losses.
1918年西班牙大流感以后,流感病毒感染猪群演变为经典猪流感(H1/CS)分支,1976年欧洲H1N1亚型禽源流感病毒感染猪群,并逐渐替代CS分支,成为猪流感病毒主要分支,即欧亚类禽猪源流感病毒分支(H1/EA),中国香港在2001年首次分离到EA分支的流感病毒,另外H1和H3亚型季节性流感(HS)则在猪群中呈现明显的地域性分布。2009年从墨西哥爆发了席卷全球的流感大流行,并在中国猪群中广泛传播,通过遗传进化分析后表明猪源、人源和禽源流感病毒重组形成的新型流感病毒就是新爆发的pdm/09。After the Spanish flu pandemic in 1918, the influenza virus infected swine herds evolved into the classical swine influenza (H1/CS) branch. In 1976, the European H1N1 subtype avian influenza virus infected pigs and gradually replaced the CS branch to become the main branch of swine influenza virus. , that is, the Eurasian avian swine-origin influenza virus branch (H1/EA). In 2001, Hong Kong, China was the first to isolate the influenza virus of the EA branch. In addition, the H1 and H3 subtypes of seasonal influenza (HS) appeared obviously in pigs. geographical distribution. In 2009, an influenza pandemic that swept the world broke out from Mexico and spread widely among pigs in China. Through genetic evolution analysis, it was shown that the new influenza virus formed by the recombination of swine, human and avian influenza viruses was the new outbreak of pdm/ 09.
猪的呼吸道上皮细胞具有同时表达α-2,3和α-2,6两种流感病毒的受体的能力,因而猪可同时感染人、猪和禽源流感病毒,普遍认为猪是流感病毒的“混合器”。中国猪群内呈现多种亚型流感病毒共存的现状,自pdm/09感染中国猪群后,pdm/09逐渐成为中国猪群内主要的流行分支,并开始在中国猪群中广泛存在。研究表明pdm/09已经与其它流感病毒发生重组,形成新型流感病毒,并开始在猪群中传播。所以加强猪群流感病毒的检测对公共卫生具有非常重要的意义,为此国内外学者对猪流感病毒的诊断与检测做了大量研究,研制出PCR、ELISA和Real-Time PCR等检测方法,但这些方法费事费力,需要昂贵的实验仪器和熟练的操作技能来完成,不适用于检测区域性猪流感病毒的分布情况,常用的也是最基本的检测区域性猪流感病毒分布情况的方法是血凝和血凝抑制试验,但由于动物血清中含有非特异性凝血因子,常造成结果的假阳性,对检测工作造成阻碍,另外由于检测工作量大,试验样本多,在结果数据的分析上,易造成紊乱。The respiratory epithelial cells of pigs have the ability to express the receptors of α-2,3 and α-2,6 influenza viruses at the same time, so pigs can be infected with human, porcine and avian influenza viruses at the same time. It is generally believed that pigs are the parent of influenza viruses. "mixer". There are multiple subtypes of influenza viruses coexisting in Chinese swine herds. Since pdm/09 infected Chinese swine herds, pdm/09 has gradually become the main epidemic branch in Chinese swine herds and began to widely exist in Chinese swine herds. Studies have shown that pdm/09 has recombined with other influenza viruses to form a new influenza virus and began to spread in pigs. Therefore, strengthening the detection of swine influenza virus is of great significance to public health. For this reason, scholars at home and abroad have done a lot of research on the diagnosis and detection of swine influenza virus, and developed detection methods such as PCR, ELISA and Real-Time PCR. These methods are time-consuming and laborious, requiring expensive experimental instruments and skilled operating skills to complete, and are not suitable for detecting the distribution of regional swine influenza viruses. The commonly used and most basic method for detecting the distribution of regional swine influenza viruses is hemagglutination and hemagglutination inhibition test, but because animal serum contains non-specific coagulation factors, it often causes false positive results and hinders the detection work. In addition, due to the heavy detection workload and many test samples, it is easy to cause disorder.
发明内容Contents of the invention
为了解决血凝和血凝抑制试验受非特异性凝血因子干扰以及数据分析难的问题,本发明拟提供一种检测区域性猪流感病毒亚型分布的方法,该方法简单有效、成本低廉,适用于地方性检测工作的开展。In order to solve the problem that the hemagglutination and hemagglutination inhibition tests are interfered by non-specific coagulation factors and the data analysis is difficult, the present invention intends to provide a method for detecting the distribution of regional swine influenza virus subtypes, which is simple, effective, low-cost, and suitable for The development of local testing work.
一种检测区域性猪流感病毒亚型分布的方法,包括以下步骤:A method for detecting regional swine influenza virus subtype distribution, comprising the following steps:
步骤一、采集血清样品,按照不同地点将其分成不同组,对每组中的每份血清样品进行处理,处理步骤为:在每30μL血清样品中加入15μL 8mg/mL的胰酶溶液,56℃水浴处理30min,加入60μL 2.3mg/mL的高铁酸钠水溶液和60μL 体积百分数为3%的过氧化氢水溶液,混匀后室温静置15min,再加60μL质量体积百分数为0.5%的聚乙二醇水溶液,混匀后室温静置10min,与75μL的PBS溶液混合,得待检血清;取待检血清和体积分数为1%的鸡红细胞悬液,按照1:1的体积比将两者进行混合,鸡红细胞呈泪滴状下沉,血清样品处理成功,待检血清用于后续步骤;Step 1. Collect serum samples, divide them into different groups according to different locations, and process each serum sample in each group. The processing steps are: add 15 μL of 8 mg/mL trypsin solution to each 30 μL serum sample, and heat at 56 °C Treat in a water bath for 30 minutes, add 60 μL of 2.3 mg/mL sodium ferrate aqueous solution and 60 μL of 3% hydrogen peroxide aqueous solution, mix well and let stand at room temperature for 15 minutes, then add 60 μL of 0.5% by mass volume percent polyethylene glycol Aqueous solution, after mixing, let stand at room temperature for 10 minutes, mix with 75 μL of PBS solution to obtain the serum to be tested; take the serum to be tested and chicken red blood cell suspension with a volume fraction of 1%, and mix the two according to the volume ratio of 1:1 , the chicken erythrocytes sink in a teardrop shape, the serum sample is successfully processed, and the serum to be tested is used in the subsequent steps;
步骤二、在V型微量反应板的2-12孔中分别加入50μL的PBS溶液;在第1孔中加入100μL待检抗原,将其吸出50μL置于第2孔中,混匀后从第2孔中吸出50μL置于第3孔中,依次进行系列倍比稀释至第11孔,弃最终的50μL;在第1至12孔中加入50μL的1%的鸡红细胞悬液,将V型微量反应板置于微量振荡器上处理1-2min,37℃静置15min,观察结果,获取待检抗原的血凝单位;Step 2: Add 50 μL of PBS solution to the 2-12 wells of the V-type micro-reaction plate; add 100 μL of the antigen to be tested in the 1st well, suck out 50 μL of it and place it in the 2nd well, mix well and remove from the 2nd well Aspirate 50 μL from the well and place it in the third well, serially dilute to the 11th well, and discard the final 50 μL; add 50 μL of 1% chicken red blood cell suspension to the 1st to 12th wells, and the V-type microreaction Place the plate on a micro shaker for 1-2 minutes, let it stand at 37°C for 15 minutes, observe the results, and obtain the hemagglutination unit of the antigen to be tested;
步骤三、根据步骤二的结果配制浓度为4个血凝单位的待检抗原,在V型微量反应板的2-11孔中分别加入25μL的PBS溶液,第12孔加入50μL的PBS溶液;在第1孔加入50μL处理好的待检血清,将其吸出25μL置于第2孔中,混匀后从第2孔中吸出25μL置于第3孔中,依次进行系列倍比稀释至第10孔,弃最终的25μL;在第1-11孔中分别加入25μL 浓度为4 个血凝单位的待检抗原,37℃静置30分钟,第1-12孔中分别加入50μL的1%的鸡红细胞悬液;以完全抑制4个血凝单位待检抗原的待检血清最高稀释倍数作为血清抗体的效价,血清抗体效价≥40时为阳性;Step 3. Prepare the antigen to be tested with a concentration of 4 hemagglutination units according to the results of step 2. Add 25 μL of PBS solution to wells 2-11 of the V-type microreaction plate, and add 50 μL of PBS solution to the 12th well; Add 50 μL of the treated serum to be tested in the first well, aspirate 25 μL and place it in the second well, after mixing, aspirate 25 μL from the second well and place it in the third well, and serially dilute to the tenth well , discard the final 25 μL; add 25 μL of the antigen to be tested at a concentration of 4 hemagglutination units to wells 1-11, let stand at 37°C for 30 minutes, add 50 μL of 1% chicken red blood cells to wells 1-12 Suspension; the titer of serum antibody is taken as the titer of serum antibody at the highest dilution multiple of the tested serum that completely inhibits the antigen to be tested for 4 hemagglutination units, and it is positive when the titer of serum antibody is ≥ 40;
步骤四、对步骤三获得的数据进行统计分析,比较不同组待检血清阳性率的差异是否显著。Step 4: Perform statistical analysis on the data obtained in Step 3, and compare whether the difference in the positive rate of the serum to be tested in different groups is significant.
作为进一步的优化,步骤一中胰酶溶液的配制方法:在每0.8g胰酶中加入15mL的D-Hank’s液调制成糊状,再加入40mL的D-Hank’s液搅拌至完全溶解,定容至100mL,用碳酸氢钠溶液调pH 至7.2,过滤灭菌,备用。As a further optimization, the preparation method of trypsin solution in step 1: add 15mL of D-Hank's solution to every 0.8g of trypsin to make a paste, then add 40mL of D-Hank's solution and stir until completely dissolved, and dilute to 100mL, adjust the pH to 7.2 with sodium bicarbonate solution, filter and sterilize, set aside.
作为进一步的优化,V型微量反应板在使用前进行清洗,清洗步骤为:将浸泡有75%乙醇的棉签置于V型微量反应板的每孔内旋转,然后用蒸馏水冲洗2遍,再用双蒸水洗涤3遍,置37℃温箱中干燥。As a further optimization, the V-type micro-reaction plate is cleaned before use. The cleaning steps are: put a cotton swab soaked in 75% ethanol in each well of the V-type micro-reaction plate and rotate it, then rinse it twice with distilled water, and then use Wash with double distilled water three times, and dry in a 37°C incubator.
作为进一步的优化,所述1%的鸡红细胞悬液是将3只SPF鸡的混合血液,加入到其2倍体积的Alsever液中,混合摇匀;500rpm/min水平离心5min,吸出上层的Alsever液和血球沉淀物表面的白细胞层,得血球沉淀物;加入血球沉淀物20倍体积的pH=7.2的生理盐水,混合均匀,1500rpm/min离心10min进行洗涤,吸出上清后再重复洗涤3次,取沉淀;将沉淀与生理盐水以1:100的体积比混合均匀,得1%的鸡红细胞悬液。As a further optimization, the 1% chicken erythrocyte suspension is the mixed blood of 3 SPF chickens, which is added to 2 times the volume of Alsever solution, mixed and shaken; 500rpm/min horizontal centrifugation for 5min, and the upper layer of Alsever is sucked out. The white blood cell layer on the surface of the liquid and the blood cell sediment was obtained to obtain the blood cell sediment; add 20 times the volume of the blood blood sediment with pH=7.2 normal saline, mix well, wash by centrifugation at 1500rpm/min for 10min, suck out the supernatant and repeat the washing 3 times , take the precipitate; mix the precipitate with normal saline at a volume ratio of 1:100 to obtain a 1% chicken erythrocyte suspension.
有益效果:Beneficial effect:
本发明采用胰酶、高铁酸钠、过氧化氢和聚乙二醇依次作用处理血清样品,其中,胰酶通过在特定位置上降解蛋白,使细胞间结合处蛋白降解,这时细胞由于自身内部细胞骨架的张力作用下成为球形,从而使细胞分开。过氧化氢与高铁酸钠释放的原子氧作用不稳定非特异内源因子,使其趋于稳定,而高铁酸钠自身被还原,具有一定的絮凝效果,可将血清中残留的白细胞碎片和稳定的非特异性内源因子絮集,利用聚乙二醇的诱导作用,沉淀大分子物质,消除对红细胞凝集的影响,同时聚乙二醇使血清中各类物质处于疏散和活跃状态,为与鸡红细胞的反应创造了良好的环境,此方法简单有效、方便快捷,与常用非特异性凝集因子的去除方法相比,效果明显,凝集率降为0,消除了非特异性凝集因子的干扰。The present invention uses trypsin, sodium ferrate, hydrogen peroxide and polyethylene glycol to act sequentially on serum samples, wherein trypsin degrades proteins at specific positions to degrade proteins at junctions between cells. The tension of the cytoskeleton causes the cells to separate into a spherical shape. Hydrogen peroxide interacts with the atomic oxygen released by sodium ferrate to destabilize non-specific endogenous factors, making them tend to be stable, while sodium ferrate itself is reduced, which has a certain flocculation effect, which can stabilize the remaining white blood cell fragments in serum The flocculation of non-specific endogenous factors, using the induction of polyethylene glycol, precipitates macromolecular substances, and eliminates the impact on erythrocyte agglutination. The reaction of red blood cells creates a good environment. This method is simple, effective, convenient and fast. Compared with the common removal method of non-specific coagulation factors, the effect is obvious, the agglutination rate is reduced to 0, and the interference of non-specific coagulation factors is eliminated.
具体实施方式detailed description
下面通过具体的实施方式对本发明做进一步的解释。The present invention will be further explained through specific embodiments below.
一种检测区域性猪流感病毒亚型分布的方法,包括以下步骤:A method for detecting regional swine influenza virus subtype distribution, comprising the following steps:
步骤一、采集血清样品,按照不同地点将其分成不同组,对每组中的每份血清样品进行处理,处理步骤为:在每30μL血清样品中加入15μL 8mg/mL的胰酶溶液,56℃水浴处理30min,加入60μL 2.3mg/mL的高铁酸钠水溶液和60μL 体积百分数为3%的过氧化氢水溶液,混匀后室温静置15min,再加60μL质量体积百分数为0.5%的聚乙二醇水溶液,混匀后室温静置10min,与75μL的磷酸盐缓冲液(即PBS溶液)混合,得待检血清;取待检血清和体积分数为1%的鸡红细胞悬液,按照1:1的体积比将两者进行混合,鸡红细胞呈泪滴状下沉,血清样品处理成功,待检血清用于后续步骤;Step 1. Collect serum samples, divide them into different groups according to different locations, and process each serum sample in each group. The processing steps are: add 15 μL of 8 mg/mL trypsin solution to each 30 μL serum sample, and heat at 56 °C Treat in a water bath for 30 minutes, add 60 μL of 2.3 mg/mL sodium ferrate aqueous solution and 60 μL of 3% hydrogen peroxide aqueous solution, mix well and let stand at room temperature for 15 minutes, then add 60 μL of 0.5% by mass volume percent polyethylene glycol After mixing the aqueous solution, let it stand at room temperature for 10 minutes, and mix it with 75 μL of phosphate buffered saline (i.e. PBS solution) to obtain the serum to be tested; take the serum to be tested and chicken red blood cell suspension with a volume fraction of 1%, and follow the ratio of 1:1. Mix the two according to the volume ratio, the chicken red blood cells sink in a teardrop shape, the serum sample is successfully processed, and the serum to be tested is used in the subsequent steps;
其中,胰酶溶液的配制方法:在每0.8g胰酶中加入15mL的平衡盐溶液(即D-Hank’s液)调制成糊状,再加入40mL的D-Hank’s液搅拌至完全溶解,定容至100mL,用碳酸氢钠溶液调pH 至7.2,过滤灭菌,备用。Among them, the preparation method of trypsin solution: add 15mL of balanced salt solution (D-Hank's solution) to every 0.8g of trypsin to make a paste, then add 40mL of D-Hank's solution and stir until it is completely dissolved, and dilute to 100mL, adjust the pH to 7.2 with sodium bicarbonate solution, filter and sterilize, set aside.
其中,1%的鸡红细胞悬液是将3只SPF鸡的混合血液,加入到其2倍体积的阿氏液(即Alsever液)中,混合摇匀;500rpm/min水平离心5min,吸出上层的Alsever液和血球沉淀物表面的白细胞层,得血球沉淀物;加入血球沉淀物20倍体积的pH=7.2的生理盐水,混合均匀,1500rpm/min离心10min进行洗涤,吸出上清后再重复洗涤3次,取沉淀;将沉淀与生理盐水以1:100的体积比混合均匀,得1%的鸡红细胞悬液。Among them, the 1% chicken erythrocyte suspension is the mixed blood of 3 SPF chickens, added to Alsever's solution (Alsever's solution) twice the volume, mixed and shaken; 500rpm/min horizontal centrifugation for 5min, suck out the Alsever solution and the white blood cell layer on the surface of the blood cell sediment to obtain the blood cell sediment; add 20 times the volume of the blood blood sediment with pH=7.2 normal saline, mix well, wash by centrifugation at 1500rpm/min for 10min, suck out the supernatant and repeat the washing for 3 The second time, take the precipitate; mix the precipitate with normal saline at a volume ratio of 1:100 to obtain a 1% chicken erythrocyte suspension.
步骤二、在V型微量反应板的2-12孔中分别加入50μL的PBS溶液;在第1孔中加入100μL待检抗原,将其吸出50μL置于第2孔中,混匀后从第2孔中吸出50μL置于第3孔中,依次进行系列倍比稀释至第11孔,弃最终的50μL;在第1至12孔中加入50μL的1%的鸡红细胞悬液,将V型微量反应板置于微量振荡器上处理1-2min,37℃静置15min,观察结果,获取待检抗原的血凝单位;Step 2: Add 50 μL of PBS solution to the 2-12 wells of the V-type micro-reaction plate; add 100 μL of the antigen to be tested in the 1st well, suck out 50 μL of it and place it in the 2nd well, mix well and remove from the 2nd well Aspirate 50 μL from the well and place it in the third well, serially dilute to the 11th well, and discard the final 50 μL; add 50 μL of 1% chicken red blood cell suspension to the 1st to 12th wells, and the V-type microreaction Place the plate on a micro shaker for 1-2 minutes, let it stand at 37°C for 15 minutes, observe the results, and obtain the hemagglutination unit of the antigen to be tested;
其中,V型微量反应板在使用前进行清洗,清洗步骤为:将浸泡有75%乙醇的棉签置于V型微量反应板的每孔内旋转,然后用蒸馏水冲洗2遍,再用双蒸水洗涤3遍,置37℃温箱中干燥。Among them, the V-type micro-reaction plate is cleaned before use. The cleaning steps are: put a cotton swab soaked in 75% ethanol in each well of the V-type micro-reaction plate and rotate it, then rinse it twice with distilled water, and then wash it with double distilled water. Wash 3 times and dry in a 37°C incubator.
步骤三、根据步骤二的结果配制浓度为4个血凝单位的待检抗原,在V型微量反应板的2-11孔中分别加入25μL的PBS溶液,第12孔加入50μL的PBS溶液;在第1孔加入50μL处理好的待检血清,将其吸出25μL置于第2孔中,混匀后从第2孔中吸出25μL置于第3孔中,依次进行系列倍比稀释至第10孔,弃最终的25μL;在第1-11孔中分别加入25μL 浓度为4 个血凝单位的待检抗原,37℃静置30分钟,第1-12孔中分别加入50μL的1%的鸡红细胞悬液;以完全抑制4个血凝单位待检抗原的待检血清最高稀释倍数作为血清抗体的效价,血清抗体效价≥40 时为阳性;Step 3. Prepare the antigen to be tested with a concentration of 4 hemagglutination units according to the results of step 2. Add 25 μL of PBS solution to wells 2-11 of the V-type microreaction plate, and add 50 μL of PBS solution to the 12th well; Add 50 μL of the treated serum to be tested in the first well, aspirate 25 μL and place it in the second well, after mixing, aspirate 25 μL from the second well and place it in the third well, and serially dilute to the tenth well , discard the final 25 μL; add 25 μL of the antigen to be tested at a concentration of 4 hemagglutination units to wells 1-11, let stand at 37°C for 30 minutes, add 50 μL of 1% chicken red blood cells to wells 1-12 Suspension; the titer of the serum antibody is taken as the highest dilution of the tested serum that completely inhibits the antigen to be tested by 4 hemagglutination units, and it is positive when the titer of the serum antibody is ≥ 40;
步骤四、对步骤三获得的数据进行统计分析,计算不同样本量时待检血清阳性率的95%的置信区间,比较不同组待检血清阳性率的差异是否显著。Step 4: Statistically analyze the data obtained in step 3, calculate the 95% confidence interval of the positive rate of the serum to be tested at different sample sizes, and compare whether the difference in the positive rate of the serum to be tested in different groups is significant.
对非特异性凝集因子去除方法效果测定:Determination of the effect of non-specific coagulation factor removal methods:
用以下4种方法(A、B、C、D)分别处理40个血清样品,用1%鸡红细胞悬液对上述处理的血清样品进行血凝试验,测定非特异性凝集现象的去除效果。Use the following four methods (A, B, C, D) to treat 40 serum samples, and use 1% chicken red blood cell suspension to conduct a hemagglutination test on the above-mentioned treated serum samples to determine the removal effect of non-specific agglutination.
A:血清样品直接测定;A: direct determination of serum samples;
B:血清样品56℃水浴处理30min放冷后测定;B: Serum samples were treated in a water bath at 56°C for 30 minutes and then allowed to cool;
C:“胰酶-高碘酸钾-丙三醇”方法处理后测定;C: Determination after treatment by "trypsin-potassium periodate-glycerol" method;
D:采用本发明方法处理后测定。D: Measured after being treated by the method of the present invention.
测定结果如下表1所示。The measurement results are shown in Table 1 below.
其中,“1-2孔”表示仅1-2孔出现凝集的份数;“3孔及以上”表示3孔及以上出现凝集的份数。Among them, "1-2 wells" means the number of fractions where agglutination occurs only in 1-2 wells; "3 wells and above" means the fractions where agglutination occurs in 3 wells and above.
结果表明,未经处理的血清样品的非特异性凝集率高达65%,经热处理之后,非特异性凝集率有所降低,下降至37.5%,常用的“胰酶-高碘酸钾-丙三醇”法效果稍显著,但仍会对血凝抑制试验产生影响,用本发明中所述方法处理后,非特异性凝集现象消失,用于血凝抑制试验的血清样品不会产生假阳性。The results showed that the non-specific agglutination rate of untreated serum samples was as high as 65%. After heat treatment, the non-specific agglutination rate decreased to 37.5%. The commonly used "pancreatin-potassium periodate-glycerol" The effect of the method is slightly significant, but it will still affect the hemagglutination inhibition test. After being treated with the method described in the present invention, the non-specific agglutination phenomenon disappears, and the serum sample used for the hemagglutination inhibition test will not produce false positives.
实施例1 利用一种检测区域性猪流感病毒亚型分布的方法对江西省流感病毒进行血清学调查Example 1 Serological survey of influenza viruses in Jiangxi Province using a method for detecting the distribution of regional swine influenza virus subtypes
通过对江西省猪群进行H1和H3亚型猪流感病毒的血清学监测与统计分析,进而掌握江西省内猪群中流感病毒的流行情况。Through the serological monitoring and statistical analysis of H1 and H3 subtype swine influenza viruses in pigs in Jiangxi Province, the prevalence of influenza viruses in pigs in Jiangxi Province can be grasped.
步骤一、样品与信息的收集Step 1. Collection of samples and information
从2012年10月至2015年3月间,收集了覆盖江西省全省范围养殖场的血清共2005份,其中2012年为130份,2013年为430份。2014年为924份,2015年为548份。每个设区市的血清不同,其中抚州市和吉安市最多,为562和338份,其次为赣州市、上饶市、南昌市、景德镇、宜春市和九江市,分别为205、172、158、155、139和126份,其中萍乡市、新余市和鹰潭市最少,分别为65、55和30份。From October 2012 to March 2015, a total of 2005 sera were collected covering the whole province of Jiangxi Province, including 130 samples in 2012 and 430 samples in 2013. In 2014 it was 924 and in 2015 it was 548. The serums of each city divided into districts are different, among which Fuzhou and Ji’an are the most, with 562 and 338, followed by Ganzhou, Shangrao, Nanchang, Jingdezhen, Yichun and Jiujiang, respectively 205, 172, 158, 155, 139 and 126 copies, of which Pingxiang City, Xinyu City and Yingtan City were the least, with 65, 55 and 30 copies respectively.
步骤二、血清样品的收集与处理Step 2. Collection and processing of serum samples
收集来自于江西省各设区市内猪场的血清,每个养殖场至少收集15份血清。对血清样品进行处理,去除血清中的非特异性凝血因子,并于4℃保存。具体步骤为:在每30μL血清样品中加入15μL 8mg/mL的胰酶溶液,56℃水浴处理30min,加入60μL 2.3mg/mL的高铁酸钠水溶液和60μL 体积百分数为3%的过氧化氢水溶液,混匀后室温静置15min,再加60μL质量体积百分数为0.5%的聚乙二醇水溶液,混匀后室温静置10min,与75μLPBS溶液混合,得待检血清;取待检血清,按照1:1的体积比与1%的鸡红细胞悬液混合,鸡红细胞呈泪滴状下沉,血清样品处理成功,待检血清用于后续步骤。Serum from pig farms in various districts and cities in Jiangxi Province was collected, and at least 15 serum samples were collected from each farm. Serum samples were processed to remove non-specific coagulation factors in the serum and stored at 4°C. The specific steps are: add 15 μL 8 mg/mL trypsin solution to each 30 μL serum sample, treat in a water bath at 56 °C for 30 minutes, add 60 μL 2.3 mg/mL sodium ferrate aqueous solution and 60 μL 3% volume percent hydrogen peroxide aqueous solution, After mixing, let it stand at room temperature for 15 minutes, add 60 μL of 0.5% polyethylene glycol aqueous solution by mass volume percentage, mix it and let it stand at room temperature for 10 minutes, and mix it with 75 μL PBS solution to obtain the serum to be tested; take the serum to be tested according to 1: The volume ratio of 1 was mixed with 1% chicken erythrocyte suspension, the chicken erythrocytes sank in a teardrop shape, the serum sample was successfully processed, and the serum to be tested was used in the subsequent steps.
步骤三、血清HI抗体的检测与统计分析Step 3. Detection and statistical analysis of serum HI antibody
首先检测选用抗原的血凝单位,在V型微量反应板的2-12孔中分别加入50μL PBS,在第1孔中加入100μL待检抗原,吸出50μL置于第2孔中,依次按照1/2倍倍比稀释至第11孔,弃最终的50μL,在第1至12孔中加入50μL的1%的鸡红细胞悬液,37℃静置15分钟,观察结果,获得参考抗原的血凝单位。First, detect the hemagglutination unit of the selected antigen, add 50 μL of PBS to the 2-12 wells of the V-type micro-reaction plate, add 100 μL of the antigen to be tested in the first well, suck out 50 μL and place it in the second well, and follow the steps of 1/ Dilute 2 times to well 11, discard the final 50 μL, add 50 μL of 1% chicken red blood cell suspension to wells 1 to 12, let stand at 37°C for 15 minutes, observe the results, and obtain the hemagglutination unit of the reference antigen .
结果判定:结果以++++,+++,++,+,+,- 表示,其中:Result judgment: the result is represented by ++++, +++, ++, +, + , -, among which:
一层红细胞均匀地铺于孔壁上为++++;A layer of red blood cells evenly spread on the hole wall is ++++;
一层红细胞均匀铺于孔壁上,但边缘不整齐,铺的面积稍小为+++;A layer of red blood cells is evenly spread on the wall of the hole, but the edges are not neat, and the spread area is slightly smaller, which is +++;
红细胞形成一个环状,四周有小凝集块为++;Red blood cells form a ring, surrounded by small clots as ++;
红细胞形成一个小团,但边缘不光滑,四周有小凝块为+;Red blood cells form a small mass, but the edges are not smooth, and there are small clots around it as + ;
红细胞形成一个小圆圈,边缘无任何小凝块为-。Red blood cells form a small circle without any small clots at the edge -.
以++为终点,即以能完全抑制红细胞凝集的最高稀释度的倒数为终点。得一血凝滴度。将血凝滴度除以4得稀释倍数,将标准参考抗原按此倍数稀释,即为4个血凝单位。Take ++ as the end point, that is, take the reciprocal of the highest dilution that can completely inhibit erythrocyte agglutination as the end point. Get a hemagglutination titer. Divide the hemagglutination titer by 4 to obtain the dilution factor, and dilute the standard reference antigen by this factor, which is 4 hemagglutination units.
配制浓度为4个血凝单位的待检抗原,在V型微量反应板的2-11孔中分别加入25μLPBS,第12孔加入50μL PBS,在第1孔加入50μL处理好的待检血清,吸出25μL置于第2孔中,依次按照1/2倍倍比稀释至第10孔,弃最终的25μL;在第1-11孔中分别加入25μL 浓度为4 个血凝单位的待检抗原,37℃静置30分钟,第1-12孔中分别加入50μL的1%的鸡红细胞悬液;以完全抑制4个血凝单位待检抗原的待检血清最高稀释倍数作为血清抗体的效价,血清抗体效价≥40 时为阳性。Prepare the antigen to be tested with a concentration of 4 hemagglutination units, add 25 μL PBS to the 2-11 wells of the V-type micro-reaction plate, add 50 μL PBS to the 12th well, add 50 μL of the processed serum to be tested to the 1st well, and aspirate 25 μL was placed in the second well, and then diluted to the 10th well according to 1/2 doubling ratio, and the final 25 μL was discarded; 25 μL of the antigen to be tested at a concentration of 4 hemagglutination units was added to the 1-11 wells respectively, 37 Stand still at ℃ for 30 minutes, add 50 μL of 1% chicken red blood cell suspension to the 1-12 wells respectively; take the highest dilution factor of the serum to be tested that completely inhibits the antigen to be tested by 4 hemagglutination units as the titer of the serum antibody, and the titer of the serum antibody Antibody titer ≥ 40 is positive.
步骤四、数据统计与分析Step 4. Data statistics and analysis
使用IBM SPSS Statistics 20和Graphpad Prism 5对获得的数据进行统计分析,计算不同样本量时的血清阳性率的95%的置信区间,比较不同组血清阳性率的差异是否显著。结果如下:The obtained data were statistically analyzed using IBM SPSS Statistics 20 and Graphpad Prism 5, and the 95% confidence intervals of the seropositive rates at different sample sizes were calculated to compare whether the differences in the seropositive rates in different groups were significant. The result is as follows:
(1) H1和H3亚型流感病毒流行情况(1) Epidemic situation of H1 and H3 subtype influenza viruses
通过血凝抑制试验检测了江西省收集的2005份血清中流感病毒的抗体水平,其中H1总阳性率为34.76%,95%置信区间为32.68%-36.89%,显著高于其他亚型流感病毒,H3流感病毒血清抗体阳性率为23.69%。H1亚型流感病毒中pdm/09分支流感病毒的血清抗体阳性率最高,达到28.73%,并显著高于其它分支的流感病毒,其后依次为H1/CS和H1/EA。结果如下表2所示。The antibody level of influenza virus in 2005 sera collected in Jiangxi Province was detected by hemagglutination inhibition test, and the total positive rate of H1 was 34.76%, with a 95% confidence interval of 32.68%-36.89%, which was significantly higher than other subtypes of influenza virus. The seropositive rate of H3 influenza virus was 23.69%. Among H1 subtype influenza viruses, pdm/09 branch influenza virus had the highest seropositive rate of 28.73%, which was significantly higher than other branch influenza viruses, followed by H1/CS and H1/EA. The results are shown in Table 2 below.
(2)H1和H3亚型流感病毒共感染情况(2) Co-infection with H1 and H3 subtype influenza viruses
若血凝抑制试验检测抗体阳性,则认为曾经感染过此分支的流感病毒,若两种或者以上的抗原的抗体出现阳性,则认为此猪曾感染过两个甚至两个以上分支的流感病毒,通过对实验数据进行统计分析发现:H1亚型的多个分支之间存在大量的共感染病例,pdm/09和EA/H1N1之间的共感染率为11.62%,pdm/09与CS的共感染率为6.38%,而EA与CS的共感染率为5.19%;H1和H3亚型流感病毒抗体阳性率为6.78 %,H1各分支的流感病毒也均出现与H3亚型流感病毒的共感染病例。结果如下表3所示。If the hemagglutination inhibition test detects a positive antibody, it is considered that the pig has been infected with the influenza virus of this branch. If the antibody of two or more antigens is positive, it is considered that the pig has been infected with two or more than two branches of the influenza virus. Through statistical analysis of the experimental data, it was found that there were a large number of co-infection cases among multiple branches of the H1 subtype, the co-infection rate between pdm/09 and EA/H1N1 was 11.62%, and the co-infection rate between pdm/09 and CS The co-infection rate of EA and CS was 5.19%; the positive rate of H1 and H3 subtype influenza virus antibody was 6.78%, and the co-infection cases of H1 subtype influenza virus and H3 subtype influenza virus also appeared . The results are shown in Table 3 below.
(3)江西省不同地区流感病毒的流行情况(3) The prevalence of influenza viruses in different areas of Jiangxi Province
对江西省内11个设区市的H1和H3亚型流感病毒的血清学的检测结果进行统计分析后,发现上饶市和吉安市的pdm/09分支的流感病毒的抗体阳性率最高,分别为44.77%和29.88%,并且显著高于该地区其他分支流感病毒的抗体阳性率;鹰潭市、景德镇市、新余市和宜春市的H3/L22的抗体阳性率最高,分别为50.00%、25.16%、43.64%以及26.62%,并显著高于当地其他分支的SIV的抗体阳性率;南昌市的pdm/09和H1/CS分支流感病毒的抗体阳性率最高,分别为49.37%和41.77%,两个分支流感病毒的抗体阳性率差异不显著;九江市、赣州市、萍乡市和抚州市内猪群的pdm/09和H3/L22分支的流感病毒抗体阳性率最高,并显著高于H1/EA和H1/CS的阳性率。结果如下表4所示。After statistical analysis of the serological detection results of H1 and H3 subtype influenza viruses in 11 districted cities in Jiangxi Province, it was found that the antibody positive rate of the pdm/09 branch in Shangrao City and Ji'an City was the highest, respectively 44.77% and 29.88%, and significantly higher than the antibody positive rates of other branches of influenza viruses in the region; Yingtan City, Jingdezhen City, Xinyu City and Yichun City had the highest antibody positive rates of H3/L22, respectively 50.00%, 25.16%, 43.64% and 26.62%, which were significantly higher than the antibody-positive rates of other branches of SIV in the local area; the antibody-positive rates of the pdm/09 and H1/CS branch influenza viruses in Nanchang were the highest, respectively 49.37% and 41.77%, and the two branches The difference in the positive rate of influenza virus antibody was not significant; the positive rate of influenza virus antibody in the pdm/09 and H3/L22 branches of pig populations in Jiujiang City, Ganzhou City, Pingxiang City and Fuzhou City was the highest, and was significantly higher than that of H1/EA and H1 /CS positive rate. The results are shown in Table 4 below.
(4)2012年至2015年江西省猪群流感病毒流行情况(4) Epidemic situation of swine influenza virus in Jiangxi Province from 2012 to 2015
通过对2012年至2015年不同分支流感病毒血清阳性率进行统计分析后,发现2013年江西省收集的血清中pdm/09分支流感病毒的血清抗体阳性率为36.74%,显著高于其他年份,并显著高于同期其他分枝和H3亚型流感病毒抗体阳性率,2014年开始下降,到2015年阳性率降低为20.44%;与pdm/09相反,H3流感病毒的血清阳性率逐渐上升,由2012年的4.85%上升至2015年的41.24%。2012年至2015年间H1/HS的抗体阳性率相对稳定,而H1/CS和H1/EA则在2014年达到最高,阳性率分别达到17.21%和16.23%。结果如表3和下表5所示。After statistical analysis of the seropositive rates of different branch influenza viruses from 2012 to 2015, it was found that the serum antibody positive rate of the pdm/09 branch influenza virus in the serum collected in Jiangxi Province in 2013 was 36.74%, which was significantly higher than that in other years, and Significantly higher than other branches and H3 subtype influenza virus antibody positive rate in the same period, it began to decline in 2014, and the positive rate decreased to 20.44% in 2015; in contrast to pdm/09, the seropositive rate of H3 influenza virus gradually increased, from 2012 to 20.44%. 4.85% in 2015 rose to 41.24% in 2015. The antibody positive rate of H1/HS was relatively stable between 2012 and 2015, while H1/CS and H1/EA reached the highest in 2014, with positive rates of 17.21% and 16.23%, respectively. The results are shown in Table 3 and Table 5 below.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610837384.1A CN106442986B (en) | 2016-09-21 | 2016-09-21 | A kind of method of the detection zone swine influenza virus subtype distribution of non-disease diagnose and treat purpose |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610837384.1A CN106442986B (en) | 2016-09-21 | 2016-09-21 | A kind of method of the detection zone swine influenza virus subtype distribution of non-disease diagnose and treat purpose |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106442986A true CN106442986A (en) | 2017-02-22 |
CN106442986B CN106442986B (en) | 2018-05-18 |
Family
ID=58166915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610837384.1A Active CN106442986B (en) | 2016-09-21 | 2016-09-21 | A kind of method of the detection zone swine influenza virus subtype distribution of non-disease diagnose and treat purpose |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106442986B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111323581A (en) * | 2020-03-03 | 2020-06-23 | 广州鸿泉生物科技有限公司 | Influenza hemagglutination inhibition test detection method |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426296A (en) * | 2000-04-28 | 2003-06-25 | 生物生命股份有限公司 | Hemostat agent, method and carrier for applying blood clotting agent |
CN101320043A (en) * | 2008-04-14 | 2008-12-10 | 秦凤云 | Method for simple detection of layer bird flu and newcastle disease immune antibody |
CN101957362A (en) * | 2010-09-02 | 2011-01-26 | 洛阳普莱柯生物工程有限公司 | Efficacy test method of infectious bronchitis vaccines and application thereof |
CN103543257A (en) * | 2013-10-25 | 2014-01-29 | 广州市华南农大生物药品有限公司 | Preparation method of sensitized chicken erythrocyte as well as IBV (Infectious Bronchitis Virus) detection kit |
CN104730259A (en) * | 2015-03-12 | 2015-06-24 | 青岛易邦生物工程有限公司 | Method for detecting hemagglutination inhibition antibody of chicken infectious bronchitis |
CN105866427A (en) * | 2016-04-22 | 2016-08-17 | 北京市农林科学院 | Composition, and application thereof in infectious bronchitis antibody determination |
-
2016
- 2016-09-21 CN CN201610837384.1A patent/CN106442986B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1426296A (en) * | 2000-04-28 | 2003-06-25 | 生物生命股份有限公司 | Hemostat agent, method and carrier for applying blood clotting agent |
CN101320043A (en) * | 2008-04-14 | 2008-12-10 | 秦凤云 | Method for simple detection of layer bird flu and newcastle disease immune antibody |
CN101957362A (en) * | 2010-09-02 | 2011-01-26 | 洛阳普莱柯生物工程有限公司 | Efficacy test method of infectious bronchitis vaccines and application thereof |
CN103543257A (en) * | 2013-10-25 | 2014-01-29 | 广州市华南农大生物药品有限公司 | Preparation method of sensitized chicken erythrocyte as well as IBV (Infectious Bronchitis Virus) detection kit |
CN104730259A (en) * | 2015-03-12 | 2015-06-24 | 青岛易邦生物工程有限公司 | Method for detecting hemagglutination inhibition antibody of chicken infectious bronchitis |
CN105866427A (en) * | 2016-04-22 | 2016-08-17 | 北京市农林科学院 | Composition, and application thereof in infectious bronchitis antibody determination |
Non-Patent Citations (2)
Title |
---|
李晓华: "血凝抑制试验的影响因素", 《龙岩师专学报》 * |
王静: "血凝、血凝抑制试验在生产中的应用", 《养禽与禽病防治》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111323581A (en) * | 2020-03-03 | 2020-06-23 | 广州鸿泉生物科技有限公司 | Influenza hemagglutination inhibition test detection method |
Also Published As
Publication number | Publication date |
---|---|
CN106442986B (en) | 2018-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102851392B (en) | Animal epidemic disease three-color fluorescence RT-PCR detection kit and detection method thereof | |
CN105527442B (en) | A kind of hog cholera antibody detecting system and preparation method thereof | |
Andreani et al. | Atypical cowpox virus infection in smallpox-vaccinated patient, France | |
CN104109206A (en) | Monoclonal antibodies against duck Tembusu virus, antigen detection kit and application | |
Malekshahi et al. | Molecular characterization of the glycoprotein and fusion protein in human respiratory syncytial virus subgroup A: Emergence of ON-1 genotype in Iran | |
CN103305634A (en) | Isothermal amplication rapid detection method of H7N9 avian influenza virus | |
CN106442986B (en) | A kind of method of the detection zone swine influenza virus subtype distribution of non-disease diagnose and treat purpose | |
CN109239342B (en) | QX type IBV hemagglutination inhibition test antigen and preparation method and application thereof | |
CN103063854B (en) | Solid-phase competition ELISA (Enzyme-Linked Immuno Sorbent Assay) detection kit of duck tembusu virus antibody | |
CN101776687A (en) | Indirect ELISA method for detecting goose circovirus antibodies | |
CN103235139A (en) | A rapid antigen detection method for inactivated oil emulsion vaccine against avian influenza finish products | |
CN108088995A (en) | Bird flu hemagglutination-inhibition test detection method | |
CN106771121A (en) | A kind of foot and mouth disease virus colloidal gold strip, cause of disease quick detection kit and preparation method thereof | |
CN101320043A (en) | Method for simple detection of layer bird flu and newcastle disease immune antibody | |
CN102002480B (en) | Anti-H3N2 swine influenza virus hemagglutinin protein monoclonal antibody, hybridoma cell strain and antigen capturing ELISA kit | |
CN103543257A (en) | Preparation method of sensitized chicken erythrocyte as well as IBV (Infectious Bronchitis Virus) detection kit | |
CN104203972A (en) | Influenza c virus | |
Redwan et al. | Prevalence study of Hepatitis B virus (HBV) infection by serological techniques in Jeddah, Saudi Arabia | |
CN102605105B (en) | Diagnostic kit used for identifying reverse transcription-composite nested polymerase chain reaction of swine fever vaccine strains and pandemic strains and detection method | |
CN106033038A (en) | A method of processing serum used for avian infectious bronchitis hemagglutination inhibition assays | |
CN103837682B (en) | A kind of duck novel banzi virus BYDV antibody ELISA detection kit | |
Al-zobaei | Comparison between haemagglutination inhibition and complement fixation tests in detecting antibodies responses following influenza viral infection | |
CN101046477A (en) | HBV-DNA kit for quantitative enzyme-linked measurment of heaptitis B core antigen | |
CN104099298A (en) | Canine parvovirus latex detection reagent, detection method and application | |
Gakhar et al. | Use of Dried Blood Spot Samples in HCV‐, HBV‐, and Influenza‐Related Epidemiological Studies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |